NEET-PG 2012 Practice Questions

Q: Which type of cataract is associated with the phenomenon known as 'second sight'?

Nuclear cataract. ***Nuclear cataract*** - A nuclear cataract causes the lens to become more **myopic** or nearsighted due to an increase in its **refractive index**. - This temporary increase in nearsightedness can allow elderly individuals who previously needed reading glasses (due to presbyopia) to read without them, a phenomenon known as "**second sight**." *Cortical cataract* - Cortical cataracts primarily affect the **outer layer or cortex** of the lens, appearing as spokes or wedges radiating from the periphery. - They tend to cause **glare** and **reduced peripheral vision**, but generally do not improve near vision. *Zonular cataract* - A zonular cataract is a **congenital type of cataract**, characterized by opacity in specific layers (lamellae) of the lens, often in the fetal nucleus. - It does not typically lead to the "second sight" phenomenon, as it is present from birth and affects vision differently. *Punctate cataract* - Punctate cataracts are small, **dot-like opacities** scattered throughout the lens, often considered benign. - They are usually **incidental findings** and rarely cause significant visual disturbances or "second sight."

Q: Which of the following statements is false about phacolytic glaucoma?

Primarily caused by iris-lens contact. ***Primarily caused by iris-lens contact*** - This statement is **FALSE** because **phacolytic glaucoma** is caused by the leakage of **lens proteins** from a **hypermature cataract** into the **anterior chamber**, not by iris-lens contact. - **Iris-lens contact** is the mechanism in **pupillary block glaucoma** and **acute angle-closure glaucoma**, not in phacolytic glaucoma. - The pathophysiology involves **macrophages** engulfing leaked lens proteins and obstructing the **trabecular meshwork**. *Open angle glaucoma* - This statement is true because **phacolytic glaucoma** is definitively an **open-angle glaucoma**. - It involves obstruction of the **trabecular meshwork** by **macrophages** laden with **lens proteins**, which is an open-angle mechanism. - The angle remains anatomically open but functionally blocked. *Seen in hypermature stage of cataract* - This statement is true because **phacolytic glaucoma** develops when the **lens capsule** of a **hypermature (Morgagnian) cataract** becomes permeable. - This permeability allows **high-molecular-weight lens proteins** to leak into the **aqueous humor**. *Lens induced glaucoma* - This statement is true as **phacolytic glaucoma** is a specific type of **lens-induced glaucoma**, arising from the toxic effects of **leaked lens material**. - Other forms of **lens-induced glaucoma** include **phacomorphic glaucoma**, **lens-particle glaucoma**, and **phacoanaphylactic glaucoma**.

Q: Orphan Annie nuclei are characteristic of which of the following?

Papillary thyroid carcinoma. ***Papillary carcinoma thyroid***[1][2] - Characterized by **Orphan Annie nuclei**[1], which are large and round with a clear or empty appearance due to the presence of intranuclear cytoplasmic inclusions[1]. - Often associated with **thyroid follicular structures** and is the most common type of thyroid cancer[2]. *Meningioma* - Typically presents with **dural-based tumors** and does not exhibit Orphan Annie nuclei. - Histologically, it may demonstrate **whorled patterns** or calcifications instead. *Carcinoma pituitary* - Involves **adenomatous changes** in the pituitary gland but does not demonstrate the characteristic Orphan Annie nuclei. - More commonly shows **varied cellular morphology** depending on the type of secretory cells (e.g., prolactin, ACTH). *Paraganglioma* - Derived from **neuroendocrine cells**, and presents with **zellballen pattern** rather than Orphan Annie nuclei. - Often shows **chromaffin cells** and is typically associated with catecholamine secretion. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Endocrine System, p. 1099. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 429-430.

Q: Which of the following is the most likely proliferating breast mass?

Fibroadenoma. **Fibroadenoma** - A **fibroadenoma** is a benign **biphasic breast tumor** composed of both glandular and stromal tissue, making it a common proliferating mass [3]. - It is often seen in **young women** and typically presents as a firm, movable, non-tender lump [3]. *Duct ectasia* - **Duct ectasia** is a non-proliferative condition characterized by dilation of the **subareolar ducts**, often with inflammation and fibrosis. - It is more commonly associated with **nipple discharge** and **periductal inflammation** rather than being a primary proliferating mass. *Adenosis* - **Adenosis** refers to an increase in the number of **glands or lobules** within the breast parenchyma, which can be sclerosing or florid [2]. - While it involves increased glandular elements, it is generally considered a **benign proliferative change** and less likely to form a distinct, palpable mass compared to a fibroadenoma [1], [4]. *Papilloma* - A **papilloma** is a benign epithelial proliferation within a **duct**, characterized by a central fibrovascular core [2]. - It commonly presents with **nipple discharge**, often bloody, and is typically a smaller lesion within the ductal system rather than a large, palpable proliferating mass [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, pp. 1052-1054. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 446-447. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Liver And Biliary System Disease, pp. 448-449. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, p. 1052.

Q: Most common site for medulloblastoma is-

Cerebellum. ***Cerebellum*** - **Medulloblastoma** is a highly malignant primary brain tumor that characteristically arises in the **cerebellum** [1]. - It is the most common malignant brain tumor in children, typically originating from the **roof of the fourth ventricle**. *Pituitary* - The **pituitary gland** is mostly associated with **adenomas**, which are benign tumors arising from anterior pituitary cells. - Tumors like **craniopharyngiomas** can also be found in the sellar region, but medulloblastomas do not originate here. *Cerebrum* - The **cerebrum** is the most common site for **gliomas** (e.g., glioblastoma multiforme) and metastatic tumors in adults. - Medulloblastoma specifically originates from primitive neuroectodermal cells in the posterior fossa [1]. *Pineal gland* - The **pineal gland** is associated with **pinealomas** (e.g., pineoblastoma, pineocytoma) and **germinomas** [2]. - These are distinct from medulloblastomas in their cellular origin and typical anatomical location.

Q: ER positive status in carcinoma breast indicates?

Prognosis. ***Prognosis*** - **ER positive status** in breast cancer indicates a better prognosis, as these tumors often respond well to hormone therapy [1][2]. - Patients with **ER positive** breast cancer usually have a lower risk of metastasis compared to **ER negative** tumors, making the outcome more favorable [1]. *Site* - ER status does not provide information regarding the **anatomical location** of the breast cancer, as it can be present in different sites of the breast. - It primarily focuses on the **biologic characteristics** of the tumor rather than its site of occurrence [1]. *None* - Selecting 'None' suggests that ER positive status has no relevance, which is incorrect as it is significant for treatment and prognosis [1]. - It is a crucial indicator for deciding on **endocrine therapy**, impacting management strategies in breast cancer patients [1]. *Etiology* - ER positive status does not directly indicate the **cause** of breast cancer, as various genetic and environmental factors contribute to its development. - It mainly reflects tumor behavior and response to therapies, not the **underlying factors** that lead to the disease [1]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, p. 1056. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Breast, pp. 1064-1066.

Q: Which of the following best describes a Type B adverse drug reaction?

Unpredictable bizarre reaction. ***Unpredictable bizarre reaction*** - Type B reactions are **unpredictable**, **bizarre**, and not directly related to the drug's known pharmacological actions. - They often involve **immunological reactions** or genetic predispositions, such as allergies or idiosyncratic responses. *Augmented effect of drug* - This describes a **Type A** adverse drug reaction, which is predictable and results from an **exaggerated pharmacological effect** of the drug. - It is typically dose-dependent and can be managed by adjusting the dosage. *Effect seen on chronic use of drug* - This description can apply to several types of adverse reactions, but it commonly relates to **Type C (chronic) reactions**, where effects occur only after prolonged exposure. - These reactions might be due to **cumulative toxicity** or adaptive changes in the body. *Delayed effect of drug* - This aligns with **Type D (delayed) adverse drug reactions**, which manifest long after the drug exposure has ended or after a period of latency. - Examples include **carcinogenesis** or teratogenesis, occurring months or years later.

Q: Which of the following statements about dopamine is false?

Causes increase in GI Ischemia. ***Causes increase in GI Ischemia*** (FALSE Statement) - This statement is **incorrect and misleading** as dopamine does not primarily "cause increase in GI ischemia" - While dopamine at **higher doses** can cause **splanchnic vasoconstriction** via alpha-1 receptors, this is not characterized as "causing GI ischemia" in standard pharmacology - GI ischemia is a potential adverse effect in susceptible patients, but not a primary pharmacological effect or standard clinical description of dopamine *Positive inotropic* (TRUE Statement) - Dopamine is a **catecholamine** with dose-dependent effects; at **moderate doses (5-10 mcg/kg/min)**, it stimulates **beta-1 adrenergic receptors** in the heart - This beta-1 stimulation leads to increased **myocardial contractility** and **heart rate**, thus exerting a **positive inotropic effect** - This is a well-established therapeutic effect of dopamine *Improves renal perfusion* (TRUE Statement) - At **low doses (0.5-3 mcg/kg/min)**, dopamine selectively activates **dopamine-1 (D1) receptors** in the renal vasculature - This activation causes **renal vasodilation**, leading to increased **renal blood flow**, improved **glomerular filtration rate**, and enhanced **sodium excretion** - This "renal dose" effect is a classic pharmacological property of dopamine *Causes Vasoconstriction* (TRUE Statement) - At **high doses (>10 mcg/kg/min)**, dopamine primarily stimulates **alpha-1 adrenergic receptors** - This leads to generalized **vasoconstriction**, increasing **systemic vascular resistance** and **blood pressure** - This dose-dependent alpha effect is well-documented

Q: Which of the following is a centrally acting antihypertensive drug?

Methyldopa. ***Methyldopa*** - **Methyldopa** is a **prodrug** that is converted to **alpha-methylnorepinephrine** in the brain, which then stimulates **alpha-2 adrenergic receptors** in the brainstem. - This stimulation reduces **sympathetic outflow** from the central nervous system, leading to decreased heart rate, stroke volume, and peripheral vascular resistance, thus lowering blood pressure. *Phenoxybenzamine* - **Phenoxybenzamine** is an **alpha-1 and alpha-2 adrenergic receptor antagonist** (non-selective alpha blocker) that primarily acts peripherally. - It causes **vasodilation** by blocking alpha-1 receptors on smooth muscle, which reduces peripheral vascular resistance. *Propranolol* - **Propranolol** is a **non-selective beta-blocker** that primarily acts on peripheral beta-adrenergic receptors. - It reduces heart rate and cardiac output by blocking **beta-1 receptors** in the heart and can also affect beta-2 receptors in the lungs and vasculature. *Prazosin* - **Prazosin** is a **selective alpha-1 adrenergic receptor antagonist** that acts primarily on peripheral blood vessels. - It causes **vasodilation** in both arteries and veins by blocking alpha-1 receptors, which reduces both preload and afterload, lowering blood pressure.

Q: Which of the following statements about Conivaptan is correct?

It is a vasopressin antagonist.. ***It is a vasopressin antagonist.*** * **Conivaptan** is a non-peptide, dual **vasopressin V1A and V2 receptor antagonist**, meaning it blocks the action of vasopressin. * By blocking vasopressin, it promotes **aquaresis** (excretion of solute-free water), which is beneficial in conditions like **hyponatremia**. * *It selectively acts on V2 receptors.* * **Conivaptan** is a **dual antagonist**, blocking both **V1A and V2 receptors**, not just V2. * **Tolvaptan**, in contrast, is a selective **V2 receptor antagonist**. * *It is administered orally.* * **Conivaptan** is typically administered intravenously, particularly in hospital settings for acute hyponatremia. * **Tolvaptan** is the orally administered vasopressin antagonist. * *All of the options.* * Since Conivaptan is not selectively acting on V2 receptors and is not administered orally, this option is incorrect.

Question 1

Which type of cataract is associated with the phenomenon known as 'second sight'?

Accepted Answer

Nuclear cataract

Answer

Cortical cataract

Answer

Zonular cataract

Answer

Punctate cataract

Question 2

Which of the following statements is false about phacolytic glaucoma?

Accepted Answer

Primarily caused by iris-lens contact

Answer

Open angle glaucoma

Answer

Lens induced glaucoma

Answer

Seen in hypermature stage of cataract

Question 3

Orphan Annie nuclei are characteristic of which of the following?

Accepted Answer

Papillary thyroid carcinoma

Answer

Paraganglioma with Zellballen pattern

Answer

Meningioma with psammoma bodies

Answer

Pituitary adenoma with atypical nuclei

Question 4

Which of the following is the most likely proliferating breast mass?

Accepted Answer

Fibroadenoma

Answer

Duct ectasia

Answer

Adenosis

Answer

Papilloma

Question 5

Most common site for medulloblastoma is-

Accepted Answer

Cerebellum

Answer

Pituitary

Answer

Cerebrum

Answer

Pineal gland

Question 6

ER positive status in carcinoma breast indicates?

Accepted Answer

Prognosis

Answer

Etiology

Answer

Site

Answer

None of the options

Question 7

Which of the following best describes a Type B adverse drug reaction?

Accepted Answer

Unpredictable bizarre reaction

Answer

Augmented effect of drug

Answer

Effect seen on chronic use of drug

Answer

Delayed effect of drug

Question 8

Which of the following statements about dopamine is false?

Accepted Answer

Causes increase in GI Ischemia

Answer

Improves renal perfusion

Answer

Causes Vasoconstriction

Answer

Positive ionotropic

Question 9

Which of the following is a centrally acting antihypertensive drug?

Accepted Answer

Methyldopa

Answer

Phenoxybenzamine

Answer

Propranolol

Answer

Prazosin

Question 10

Which of the following statements about Conivaptan is correct?

Accepted Answer

It is a vasopressin antagonist.

Answer

It selectively acts on V2 receptors.

Answer

It is administered orally.

Answer

All of the options.

NEET-PG 2012

Ophthalmology

Pathology

Pharmacology